No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
HK Stock MarketDetailed Quotes
01530 3SBIO
- 6.450
- +0.110+1.74%
Not Open Jul 5 16:08 CST
15.46BMarket Cap9.05P/E (TTM)
6.500High6.240Low4.38MVolume6.310Open6.340Pre Close28.11MTurnover0.18%Turnover Ratio9.05P/E (Static)2.40BShares7.69052wk High1.00P/B15.46BFloat Cap4.91052wk Low--Dividend TTM2.40BShs Float22.882Historical High0.102Dividend LFY4.10%Amplitude4.420Historical Low6.422Avg Price500Lot Size--Div YieldTTM1.58%Div Yield LFY
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
On June 28th, 3sbio (01530) spent approximately 58.02 million Hong Kong dollars to repurchase 9.06 million shares.
Zhitong Finance APP reported that 3sbio (01530) announced the repurchase of 9.06 million shares for approximately HKD 58.02 million on June 28, 2024.
On June 27, 3sbio (01530.HK) spent 20.56 million Hong Kong dollars to repurchase 3.28 million shares.
On June 27th, 3sbio (01530.HK) announced that it had spent HKD 20.56 million to repurchase 3.28 million shares.
On June 26, 3sbio (01530) spent HKD 9.772 million to repurchase 1.5605 million shares.
3sbio (01530) announced that it will spend HKD 9.772 million to repurchase 15 shares on June 26, 2024.
On June 25th, 3sbio spent approximately HKD 10.25 million to repurchase 1.7075 million shares.
3sbio (01530) announced that it will spend approximately 10.2513 million Hong Kong dollars on June 25, 2024 to repurchase 1.7075 million shares at a repurchase price of 5.97-6.04 Hong Kong dollars per share.
3sbio appoints Zhang Jiao'e as non-executive director.
3sbio (01530) announced that due to other business commitments, Dan Zhang retired as an independent non-executive director, which will take effect at the end of the shareholder's annual meeting. Bin Huang has resigned as a non-executive director due to reaching retirement age, effective from June 25, 2024. On the same day, Jiao'e Zhang was appointed as a non-executive director.
On June 25, 3sbio (01530.HK) spent HKD 10.251 million to repurchase 1.7075 million shares.
On June 25th, 3sbio (01530.HK) announced the repurchase of 1,707,500 shares for HKD 10.251 million.
Comments
3SBio Inc.'s lower P/E ratio is due to its forecasted growth being less than the wider market. The potential for earnings improvement may not justify a higher P/E ratio, forming a barrier for the share price.
Investors Don't See Light At End Of 3SBio Inc.'s (HKG:1530) Tunnel 1
Despite a recent drop, 3SBio's strong financials and high ROE could boost stock value long term. Significant earnings growth due to substantial profit reinvestment, though future growth may slow.
Analyst indicates that the investment risk in 3SBio is kept in check by net cash and EBIT growth. Even though managing debt could be challenging as free cash flow was only 46% of EBIT recently, the company's financials are still strong.
3SBio, with EPS growth and increased EBIT margins, is defined as a growing business. High level of insider ownership is deemed positive, aligning with shareholders' interests. Yet, the market valuation of it remains unanalysed.
Despite positive revenue and earnings growth, 3SBio's falling share price signals potential lack of investor faith or unfulfilled market expectations.
Read more
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg